Castle Biosciences Inc (CSTL)

Cost of Revenue

$81.25M

TTM · Period ending: · USD

CSTL logo

CSTL Cost of Revenue

Latest reported$81.25M
CSTL TTM Cost of Revenue ($5.30M → $81.25M)
High-resolution chart · PNG

CSTL cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Castle Biosciences Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
81,252,000
75,178,000
71,028,000
68,896,000
65,801,000
62,694,000
60,205,000
56,445,000
52,155,000
48,694,000
44,982,000
42,079,000
39,619,000
36,247,000
32,009,000
27,086,000
22,727,000
18,738,000
15,822,000
13,898,000
11,873,000
10,322,000
9,685,000
9,022,536
8,256,258
8,103,042
7,310,000
6,665,692
6,307,769
5,641,824
5,296,849
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.